Urinary tract infections (UTIs) are one of the most common bacterial diseases both in communities and in hospitalized patients, and at the same, time they are one of the most common indications for the use of antibiotics. UTI guidelines are generally available nationally or internationally, but they do not address all aspects of UTI treatment for different patient cohorts, age, gender, or comorbidities. The aim of the study was to point out the importance of stratified cumulative antibiograms at the level of individual health care facilities and the significant differences between epidemiological data, not only at the national level, but also at the local level. Our study analyses data from 383 patients with UTIs from a hospital department, General University Hospital (GUH), and 272 patients from an outpatient medical facility, Urocentrum (UC). This analysis focuses on the most common UTI causative agent, Escherichia coli, its representation as the causative agent of UTI in patients with complicated acute cystitis (N30), and its representation in complicated acute cystitis in patients with prostate cancer (C61). In addition to the frequency of occurrence, a sub-analysis of the incidence of resistance of E. coli to commonly used antibiotics by age, gender, diagnosis, and medical facility was performed. Results: The most common causative agent of UTI was E. coli. In patients with N30, it was 70% in GUH and 54% in UC, but in oncological patients with UTI, it was only 39% and 35%, respectively. In patients with UTI in C61, there was a significant difference in susceptibility of E. coli between individual health care facilities. Lower resistance was found in UC opposite to GUH isolates in ampicillin, with 29.8% vs. 65%, p = 0.001; amoxicillin/clavulanic acid, with 8.5% vs. 30%, p = 0.01; with 2.1% vs. 17.5% in pivmecillinam, p = 0.01; with 10.6% vs. 37.5% in co-trimoxazole, p = 0.003; and ciprofloxacin, with 10.6% vs. 30%, p = 0.04. The study shows significant differences in the sensitivity of urinary E. coli isolates in patients in relation to age, gender, medical devices, and the presence of comorbidities.

Clinical Microbiology and ATB Centre General University Hospital 128 08 Prague Czech Republic

Czech Institute of Informatics Robotics and Cybernetics Czech Technical University Prague 160 00 Prague Czech Republic

Department of Plant Sciences University of Cambridge Cambridge CB2 3EA UK

Department of Urology University Hospital Motol 2nd Faculty of Medicine Charles University 150 06 Prague Czech Republic

Urocentrum Praha 120 00 Prague Czech Republic

Zobrazit více v PubMed

Flores-Mireles A.L., Walker J.N., Caparon M., Hultgren S.J. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 2015;13:269–284. doi: 10.1038/nrmicro3432. PubMed DOI PMC

Medina M., Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther. Adv. Urol. 2019;11:1756287219832172. doi: 10.1177/1756287219832172. PubMed DOI PMC

Foxman B., Barlow R., D’Arcy H., Gillespie B., Sobel J.D. Urinary tract infection: Self-reported incidence and associated costs. Ann. Epidemiol. 2000;10:509–515. doi: 10.1016/S1047-2797(00)00072-7. PubMed DOI

Zhu N.J., Weldegiorgis M., Carter E., Brown C., Holmes A., Aylin P. Economic Burden of Community-Acquired Antibiotic-Resistant Urinary Tract Infections: Systematic Review and Meta-Analysis. JMIR Public Health Surveill. 2024;10:e53828. doi: 10.2196/53828. PubMed DOI PMC

Gupta K., Grigoryan L., Trautner B. Urinary Tract Infection. Ann. Intern. Med. 2017;167:ITC49–ITC64. doi: 10.7326/AITC201710030. PubMed DOI

Kranz J., Bartoletti R., Bruyère F., Cai T., Geerlings S., Köves B., Schubert S., Pilatz A., Veeratterapillay R., Wagenlehner F.M.E., et al. European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines. Eur. Urol. 2024;86:27–41. doi: 10.1016/j.eururo.2024.03.035. PubMed DOI

Huang L., Huang C., Yan Y., Sun L., Li H. Urinary Tract Infection Etiological Profiles and Antibiotic Resistance Patterns Varied Among Different Age Categories: A Retrospective Study From a Tertiary General Hospital During a 12-Year Period. Front. Microbiol. 2022;12:813145. doi: 10.3389/fmicb.2021.813145. PubMed DOI PMC

Bader M.S., Loeb M., Brooks A.A. An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgrad. Med. 2017;129:242–258. doi: 10.1080/00325481.2017.1246055. PubMed DOI

Hrbacek J., Cermak P., Zachoval R. Current Antibiotic Resistance Trends of Uropathogens in Central Europe: Survey from a Tertiary Hospital Urology Department 2011–2019. Antibiotics. 2020;9:630. doi: 10.3390/antibiotics9090630. PubMed DOI PMC

Aronin S.I., Gupta V., Dunne M.W., Watts J.A., Yu K.C. Regional Differences in Antibiotic-resistant Enterobacterales Urine Isolates in the United States: 2018–2020. Int. J. Infect. Dis. 2022;119:142–145. doi: 10.1016/j.ijid.2022.03.052. PubMed DOI

Spoorenberg V., Hulscher M.E., Akkermans R.P., Prins J.M., Geerlings S.E. Appropriate antibiotic use for patients with urinary tract infections reduces length of hospital stay. Clin. Infect. Dis. 2014;58:164–169. doi: 10.1093/cid/cit688. PubMed DOI

Critchley I.A., Karlowsky J.A. Optimal use of antibiotic resistance surveillance systems. Clin. Microbiol. Infect. 2004;10:502–511. doi: 10.1111/j.1469-0691.2004.00911.x. PubMed DOI

World Health Organisation (WHO) Global action plan on antimicrobial resistance. Geneva: WHO; 2015. Available from Hindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: A new consensus guideline from the Clinical and Laboratory Standards Institute. Clin. Infect. Dis. 2007;44:867–873. PubMed

Eden C., Ackermann F. Making Strategy: The Journey of Strategic Management. SAGE Publications, Inc.; Thousand Oaks, CA, USA: 2013.

CLSI . Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data. Clinical and Laboratory Standards Institute; Wayne, PA, USA: 2014. Approved Guideline-Fourth Edition; CLSI document M39-A4.

Moehring R.W., Hazen K.C., Hawkins M.R., Drew R.H., Sexton D.J., Anderson D.J. Challenges in Preparation of Cumulative Antibiogram Reports for Community Hospitals. J. Clin. Microbiol. 2015;53:2977–2982. doi: 10.1128/JCM.01077-15. PubMed DOI PMC

Laupland K.B., Ross T., Pitout J.D., Church D.L., Gregson D.B. Investigation of sources of potential bias in laboratory surveillance for anti-microbial resistance. Clin. Investig. Med. 2007;30:E159–E166. doi: 10.25011/cim.v30i4.1777. PubMed DOI

Klinker K.P., Hidayat L.K., DeRyke C.A., DePestel D.D., Motyl M., Bauer K.A. Antimicrobial stewardship and antibiograms: Importance of moving beyond traditional antibiograms. Ther. Adv. Infect. Dis. 2021:8. doi: 10.1177/20499361211011373. PubMed DOI PMC

[(accessed on 10 December 2024)]. Available online: https://www.who.int/publications/i/item/9789241509763.

Simner P.J., Hindler J.A., Bhowmick T., Das S., Johnson J.K., Lubers B.V., Redell M.A., Stelling J., Erdman S.M. What’s New in Antibiograms? Updating CLSI M39 Guidance with Current Trends. J. Clin. Microbiol. 2022;60:e0221021. doi: 10.1128/jcm.02210-21. PubMed DOI PMC

Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., Harbarth S., Hindler J.F., Kahlmeter G., Olsson-Liljequist B., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012;18:268–281. doi: 10.1111/j.1469-0691.2011.03570.x. PubMed DOI

Kadri S.S., Adjemian J., Lai Y.L., Spaulding A.B., Ricotta E., Prevots D.R., Palmore T.N., Rhee C., Klompas M., Dekker J.P., et al. Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents. Clin. Infect. Dis. 2018;67:1803–1814. doi: 10.1093/cid/ciy378. PubMed DOI PMC

Neugebauer M., Ebert M., Vogelmann R. A clinical decision support system improves antibiotic therapy for upper urinary tract infection in a randomized single-blinded study. BMC Health Serv. Res. 2020;20:185. doi: 10.1186/s12913-020-5045-6. PubMed DOI PMC

Schaeffer A., Schaeffer E. Infections of the urinary tract. In: Wein A., Kavoussi L., editors. Campbell-Walsh Urology. 10th ed. Elsevier Saunders; Philadelphia, PA, USA: 2012. pp. 258–260.

Toval F., Köhler C.-D., Vogel U., Wagenlehner F., Mellmann A., Fruth A., Schmidt M.A., Karch H., Bielaszewska M., Dobrindt U. Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection. J. Clin. Microbiol. 2014;52:407–418. doi: 10.1128/JCM.02069-13. PubMed DOI PMC

Herbawi A., Abu Taha A., Aiesh B.M., Sabateen A., Zyoud S.H. Spectrum and antibiotic resistance in community- and hospital-acquired urinary tract infections among adults: Experience from a large tertiary care center in a developing country. Urologia. 2024;91:394–402. doi: 10.1177/03915603241236361. PubMed DOI

Cepas V., Soto S.M. Relationship between Virulence and Resistance among Gram-Negative Bacteria. Antibiotics. 2020;9:719. doi: 10.3390/antibiotics9100719. PubMed DOI PMC

Critchley I.A., Cotroneo N., Pucci M.J., Mendes R. The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017. PLoS ONE. 2019;14:e0220265. doi: 10.1371/journal.pone.0220265. PubMed DOI PMC

Matoušková M., Adámková V., Čechová M., Lahoda Brodská H. Konsenzuální Postupy v Léčbě Močových Infekcí. Solen; Olomouc, Czech Republic: 2022.

[(accessed on 15 December 2024)]; Available online: https://szu.gov.cz/wp-content/uploads/2023/12/PSMR_2021_EC.pdf.

Corse L., Cartwright A. Investigating trends in antibiotic resistance of Escherichia coli isolated from clinical urine specimens in the Orkney Islands. Microbiology. 2024;170:001514. doi: 10.1099/mic.0.001514. PubMed DOI PMC

Jorgensen S., Zurayk M., Yeung S., Terry J., Dunn M., Nieberg P., Wong-Beringer A. Emergency Department Urinary Antibiograms Differ by Specific Patient Group. J. Clin. Microbiol. 2017;55:2629–2636. doi: 10.1128/JCM.00481-17. PubMed DOI PMC

Goodlet K.J., Nicolau D.P., Nailor M.D. In Vitro Comparison of Ceftolozane-Tazobactam to Traditional Beta-Lactams and Ceftolozane-Tazobactam as an Alternative to Combination Antimicrobial Therapy for Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2017;61:e01350-17. doi: 10.1128/AAC.01350-17. PubMed DOI PMC

Moise P.A., Gonzalez M., Alekseeva I., Lopez D., Akrich B., DeRyke C.A., Chen W.T., Pavia J., Palermo B., Hackel M., et al. Collective assessment of antimicrobial susceptibility among the most common Gram-negative respiratory pathogens driving therapy in the ICU. JAC Antimicrob. Resist. 2021;3:dlaa129. doi: 10.1093/jacamr/dlaa129. PubMed DOI PMC

Wangchinda W., Aitken S.L., Klatt M.E., Lephart P.R., Smith A.B., Pogue J.M. A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Pneumonia Caused by Gram-Negative Bacteria in Intensive Care Units: Unit-Specific Combination Antibiograms Versus Patient-Specific Risk Factors. Open Forum Infect. Dis. 2024;11:ofae643. doi: 10.1093/ofid/ofae643. PubMed DOI PMC

Kaye K.S., Gupta V., Mulgirigama A., Joshi A.V., Scangarella-Oman N.E., Yu K., Ye G., Mitrani-Gold F.S. Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management. Clin. Infect. Dis. 2021;73:1992–1999. doi: 10.1093/cid/ciab560. PubMed DOI PMC

Golli A.-L., Zlatian O.M., Cara M.L., Olteanu M. Pre- and Post-COVID-19 Antimicrobial Resistance Pattern of Pathogens in an Intensive Care Unit. Pharmaceuticals. 2024;17:407. doi: 10.3390/ph17040407. PubMed DOI PMC

Stapleton P.J., Lundon D.J., McWade R., Scanlon N., Hannan M.M., O’Kelly F., Lynch M. Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005–2014. Ir. J. Med. Sci. 2017;186:733–741. doi: 10.1007/s11845-016-1538-z. PubMed DOI

Holm A., Cordoba G., Aabenhus R. Prescription of antibiotics for urinary tract infection in general practice in Denmark. Scand. J. Prim. Health Care. 2019;37:83–89. doi: 10.1080/02813432.2019.1569425. PubMed DOI PMC

Central Coordination Group of the National End of the Czech Republic: Antibiotic consumption in the Czech Republic in 2008–2018—Part 1. Pharmacotherapeutic Information 1/2020. [(accessed on 15 December 2024)]. Available online: http://www.sukl.cz/sukl/2020. (In Czech)